TrialAssure Offers Anonymize 3.0 That Uses Machine Learning And Artificial Intelligence To Share Info

CANTON – Pharmaceutical technology company TrialAssure announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available.

ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI) to share information with confidence, knowing that patient and company confidential information are protected.

In this latest version, ANONYMIZE 3.0 now includes the following:

Enhanced user experience, with modernized design and intuitive navigation
Centralized workbench structure for a comprehensive view of all projects and tasks in one location
Updated rule structure for a streamlined and efficient and practical anonymization decision-making
Extended support for additional types of documents, such as Microsoft Office documents and email
Improved risk score visualization to track progress in mitigating re-identification risks

“This launch ushers in a new era in anonymization to the industry, one which combines advances in AI and deep industry knowledge to drive technological progress in the pharmaceutical industry,” Zach Weingarden, Director of Product Solutions at TrialAssure and AI technology expert.

Request a demo now at https://www.trialassure.com/software/anonymize/ or https://www.trusano.ai.

About the Author: Mike Brennan

Founder of Michigan News Network, and serves as CEO, as well as Editor & Publisher of MITECHNEWS.COM. Brennan has worked since 1980 as a technology writer at newspapers in New York, NY, San Jose, CA., Seattle, WA., Memphis, TN., Detroit, MI., and London, England. He co-founded and served as managing editor of Pacific Rim News Service (SEATTLE), which developed a network of more than 100 freelance journalists in 17 Asia-Pacific countries.